ASIRO (7378) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
11 Dec, 2025Executive summary
FY2025 results exceeded revised forecasts, with revenue up 41.6% YoY to ¥6,647 million and operating income up 262.0% YoY to ¥1,419 million, driven by recovery in high-value legal media products, improved ad operations, and strong HR business performance.
Net income attributable to owners rose 620.1% YoY to ¥1,024 million, reflecting improved profitability and business focus.
Strategic divestiture of the HR staffing subsidiary (Hitotas) to focus on higher-margin segments and streamline operations.
FY2026 is positioned as a preparatory year for renewed growth from FY2027, with a conservative budget excluding new business contributions.
Financial highlights
FY2025 revenue: ¥6,647 million (up 41.6% YoY); operating income: ¥1,419 million (up 262.0% YoY); net income attributable to owners: ¥1,024 million (up 620.1% YoY).
4Q FY2025 revenue: ¥1,601 million (up 14.7% YoY, down 6.0% QoQ); operating income: ¥240 million (up 15.9% YoY, down 27.0% QoQ).
Adjusted EBITDA: ¥1,485 million (+138.1% YoY); EBITDA: ¥1,551 million (+116.3% YoY).
FY2025 operating margin: 21.4% (up 13.0pt YoY); 4Q margin: 15.0%.
FY2026 forecast: revenue ¥7,000 million (+5.3% YoY), operating income ¥1,500 million (+5.7% YoY), net income ¥980 million (−4.3% YoY).
Outlook and guidance
FY2026 growth rate expected to temporarily slow as the company invests in future growth, with high growth targeted again from FY2027.
New business initiatives planned for FY2026 are not included in the forecast due to low certainty.
Focus on diversifying media business, expanding HR placement, and scaling corporate legal insurance.
Long-term targets: ¥20 billion revenue and ¥4 billion operating income by FY2030 or FY2031.
Latest events from ASIRO
- Revenue up 8.9% YoY, profit down, dividend policy revised, and HR business divested.7378
Q1 202623 Mar 2026 - Record revenue and profit growth, HR dispatch divested, and AI-focused strategy launched.7378
Q2 202511 Dec 2025 - Record profit and margin growth, guidance raised, and new insurance product launched.7378
Q3 202512 Sep 2025 - Revenue and profit soared past targets; FY2025 outlook signals major earnings growth.7378
Q4 202413 Jun 2025 - Revenue up 44% YoY, impairments led to net loss, but outlook was raised.7378
Q3 202413 Jun 2025 - 45% YoY revenue growth, but impairment losses led to a net loss and negative EPS.7378
Q2 202413 Jun 2025 - Record Q1 growth, robust segment gains, and a major business update ahead.7378
Q1 20256 Jun 2025